Siemens Healthcare today unveils its latest in vitro diagnostics innovations during the IFCC WorldLab 2014 in Istanbul, Turkey, June 22-26. Visitors to the Siemens exhibit – themed “Test smarter. Run faster.” – can explore Siemens’ portfolio of solutions, including new central laboratory clinical analyzers designed to help customers meet growing workload demands, a next-generation drug testing platform, enhanced informatics capabilities and coagulation testing for use at the point of care.
“At Siemens, we understand the critical role that in vitro diagnostic (IVD) testing plays in the lives of patients and their families,” said Michael Reitermann, CEO, Siemens Healthcare, Diagnostics Division. “This year’s IFCC WorldLab provides an excellent platform to demonstrate how our products and services, regardless of where testing takes place, deliver clinical excellence and workflow solutions that can ultimately enable better patient care.”
New Testing, Automation and IT Offerings for the Central Lab
This year, Siemens is showcasing its latest advancements in central laboratory testing, including the ADVIA Chemistry XPT System1 and ADVIA Centaur XPT Immunoassay System1. These new clinical systems are designed to enhance workflow and streamline processes to help customers quickly, reliably and cost-effectively meet ever-increasing workload demands. For example, the systems offer new user interfaces, large touchscreens and remote service diagnostics to support easy operations. Also, each system features versatile technology enabling a broad range of testing that support clinicians in the screening, diagnosing and monitoring of the most complex diseases.
In addition, both the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System have enhanced data management capability with Siemens’ CentraLink Data Management System2 and connect to Aptio Automation2, the company’s latest track-based automation system. Booth visitors can explore Aptio Automation, including the new Tube Inspection Module2, which helps labs reduce pre-analytical errors and minimize the risk for tube mismatch, as well as featured multidisciplinary connectivity options including Sysmex CS-5100 Hemostasis System2 and ADVIA 2120i Hematology System.
Siemens is also introducing the CentraLink Data Management System Version 15, with the optional Advanced Hematology Module1. This hematology module enables labs to automate the hematology workflow resulting in reduced manual steps and increased efficiency. In addition, this latest version of the CentraLink System includes enhancements in quality control and customization to further enhance test result accuracy and enable healthcare organizations to increase productivity while reducing costs.
Experts will be on hand to discuss Siemens’ drug testing solutions, including the new Viva-ProE System1, a next generation drug-testing platform with intuitive software and enhanced components designed to lower operating costs while delivering reliable results.
Testing and Workflow Innovations at the Point of Care
With the growing demand for near-patient testing, Siemens is also showcasing its latest instruments and workflow innovations for use at the point of care (POC). This includes the Xprecia Stride Coagulation Analyzer1, a handheld coagulation system designed to perform prothrombin time testing (PT/INR).
Visitors to the booth can also learn about enhanced capabilities now offered by the RAPIDComm Data Management System2, the company’s POC informatics solution. With upgraded software, the RAPIDComm Data Management System now supports the new RAPIDComm Web Application, which allows POC coordinators, via a handheld device, to view instrument status, troubleshoot issues, and remotely manage blood gas instruments. The new software enables an interface to Siemens PEP (Personalized Education Plan) Administrator, an innovative web-based software that helps to simplify and streamline administration or staff education and training programs. With these features, the RAPIDComm Data Management System fully supports an ecosystem approach to POC testing, which encompasses device and operator management, quality control (QC), compliance reporting, competency management, inventory management, remote monitoring and mobile access.
Additionally on display is the RAPIDLab 348EX Blood Gas System2, a cost-effective solution for the measurement of pH, oxygen, carbon dioxide, electrolytes and hematocrit designed for the low-volume laboratory settings. The RAPIDLab 348EX Blood Gas System accurately delivers actionable patient test results in approximately 60 seconds on as little as 50 µL of whole blood.